Pharma.AI
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
Find alternatives to Pharma.AI
What it does
- Drug discovery
How it compares
-
Recursion OS
Both platforms screen and design drug candidates with AI/ML; Insilico's own HKEX prospectus names Recursion in its Competitive Landscape table.
The table below shows the comparison of the major global AI pharmaceutical companies.
Regulatory filing · 18 Dec 2025
Sources
- Pricing
-
Official documentation · 4 Sep 2026
No price stated anywhere on the umbrella page; it offers 'Flexible Business Models' — standalone technology access, or software combined with Pharma.ai collaborations.
- Description
-
Official documentation · 4 Sep 2026
The site's own framing: 'Commercially-available end-to-end generative AI software and automation platform designed to improve the quality and productivity of pharmaceutical research.' Navigation lists the eight modules this umbrella spans — PandaOmics, Generative Biologics, Chemistry42, inClinico, Science42:DORA, PreciousGPT, Nach01, MMAI Gym — seven of which are their own records.
- Constraints
-
Official documentation · 2 Oct 2026
Derived from the security facts on this page, from the same source.
- Security
-
Official documentation · 2 Oct 2026
Company-wide Security & IT page covering client data and IP across engagements, applied to all listed products (page names none individually). ISO 27001 refers to the ISMS. Residency is client-chosen cloud servers, recorded as custom. Training, ZDR, DPA not stated.
- Sold within
-
Pharma.AI's site offers "Flexible Business Models" ("Choose stand alone technology access or combine our software with Pharma.ai collaborations for a data-driven AI-partnership.") and a "Contact Us" route; no price or self-serve route is stated.
Also from Insilico Medicine
-
PandaOmics Platform
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base; also answers literature-review questions through ChatPandaGPT.
-
PandaOmics Box Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
-
Chemistry42 Platform
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
-
Biology42: Generative Biologics Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
-
inClinico Application
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
-
Science42: DORA Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
-
MMAI Gym Platform
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
Open Insilico Medicine in the directory
Something wrong here? Send a correction — quote this product id: insilico-medicine-pharma-ai.